logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
R

Ralph A. Tripp

university of georgia

73H-index
394Paper Count
2.2WCitation Count
Published Papers 170
Publication Date
logo
RSV nucleoprotein inhibitors in preclinical to phase II clinical development for respiratory syncytial virus infection
errExpert Opinion on Investigational Drugs
IF4.1
err2026-02-24
err0
errOAAI
errRalph A. Tripp
errShare
errSave
Intersection of inflammation and viral replication: the central role of MAPK signaling in viral respiratory infections
errFrontiers in Microbiology
IF4.5
err2026-01-24
err0
errOAAI
errRalph A. Tripp; Les P. Jones; David E. Martin
errShare
errSave
Evaluation of Probenecid Against Filovirus Replication in Vero E6 Cells
errViruses 2026, Vol. 18, Page 43
IF3.5
err2025-12-27
err0
errOAAI
errKendra Alfson; Ricardo Carrion, Jr.; Ralph A. Tripp; Chris Cirimotich; David E. Martin
errShare
errSave
Probenecid Treatment Inhibits Replication of the Edmonston Measles Virus Strain in Vero Cells
errVIRUSES-BASEL
IF3.5
err2025-11-05
err0
errOAAI
errMurray, Jackelyn; Martin, David E.; Tripp, Ralph A.
errShare
errSave
Restricting O-Linked Glycosylation of the Mucin-like Domains Enhances Immunogenicity and Protective Efficacy of a Respiratory Syncytial Virus G Glycoprotein Vaccine Antigen
errVaccines 2025, Vol. 13, Page 1004
IF3.4
err2025-09-29
err0
errOAAI
errSara M. O’Rourke; Jackelyn Murray; Maria G. Juarez; Ralph A. Tripp; Rebecca M. DuBois
errShare
errSave
Probenecid Inhibits NLRP3 Inflammasome Activity and Mitogen-Activated Protein Kinases (MAPKs)
errBIOMOLECULES
IF4.8
err2025-04-01
err1
errOAAI
errJones, Les P.; Martin, David E.; Murray, Jackelyn; Sancilio, Fred; Tripp, Ralph A.
errShare
errSave
Evaluating Probenecid or Oseltamivir Inhibition of Influenza A Virus Replication Through Plaque Assay or Fluorescent Focus Assay Using Non-Structural Protein 1-H1N1 Venus Reporter Virus
errVIRUSES-BASEL
IF3.5
err2025-02-27
err0
errOAAI
errMurray, Jackelyn; Nogales, Aitor; Martinez-Sobrido, Luis; Martin, David E.; Sancilio, Fred D.; Tripp, Ralph A.
errShare
errSave
Multiplex Detection and Quantification of Virus Co-Infections Using Label-free Surface-Enhanced Raman Spectroscopy and Deep Learning Algorithms
errACS SENSORS
IF9.1
err2025-01-28
err0
errOAAI
errYang, YJ; Cui, JH; Kumar, A; Luo, D; Murray, J; Jones, L; Chen, XY; Hülck, S; Tripp, RA; Zhao, YP
errShare
errSave
Editorial: How RSV outsmarts the host
errFRONTIERS IN IMMUNOLOGY
IF5.9
err2024-12-20
err0
errOAAI
errCormier, Stephania A.; Kauvar, Lawrence M.; Tripp, Ralph A.
errShare
errSave
Antiviral agents and therapeutics against respiratory viruses
errEXPERT OPINION ON INVESTIGATIONAL DRUGS
IF4.1
err2024-09-08
err1
PREAI
errTripp, Ralph A.; Martin, David E.
errShare
errSave
Probenecid Inhibits Human Metapneumovirus (HMPV) Replication In Vitro and in BALB/c Mice
errVIRUSES-BASEL
IF3.5
err2024-07-06
err1
errOAAI
errBergeron, Harrison C.; Crabtree, Jackelyn; Nagy, Tamas; Martin, David E.; Tripp, Ralph A.
errShare
errSave
Advancing SERS Diagnostics in COVID-19 with Rapid, Accurate, and Label-Free Viral Load Monitoring in Clinical Specimens via SFNet Enhancement
errADVANCED MATERIALS INTERFACES
IF4.4
err2024-03-31
err2
errOAAI
errYang, Yanjun; Li, Hao; Jones, Les; Murray, Jackelyn; Naikare, Hemant; Mosley, Yung-Yi C.; Spikes, Teddy; Hulck, Sebastian; Tripp, Ralph A.; Ai, Bin; Zhao, Yiping
errShare
errSave
Probenecid Inhibits Influenza A(H5N1) and A(H7N9) Viruses In Vitro and in Mice
errVIRUSES-BASEL
IF3.5
err2024-01-19
err4
errOAAI
errMurray, Jackelyn; Martin, David E.; Hosking, Sarah; Orr-Burks, Nichole; Hogan, Robert J.; Tripp, Ralph A.
errShare
errSave
Antiviral Activity of Probenecid and Oseltamivir on Influenza Virus Replication
errVIRUSES-BASEL
IF3.5
err2023-11-30
err7
errOAAI
errMurray, Jackelyn; Martin, David E.; Sancilio, Fred D.; Tripp, Ralph A.
errShare
errSave
Screening Drugs for Broad-Spectrum, Host-Directed Antiviral Activity: Lessons from the Development of Probenecid for COVID-19
errVIRUSES-BASEL
IF3.5
err2023-11-14
err7
errOAAI
errTripp, Ralph A.; Martin, David E.
errShare
errSave
Understanding immunity to influenza: implications for future vaccine development
errEXPERT REVIEW OF VACCINES
IF4.8
err2023-10-12
err5
errOAAI
errTripp, Ralph A.
errShare
errSave
Interferons-Implications in the Immune Response to Respiratory Viruses
errMICROORGANISMS
IF4.2
err2023-08-29
err8
errOAAI
errBergeron, Harrison C.; Hansen, Matthew R.; Tripp, Ralph A.
errShare
errSave
Oral Probenecid for Nonhospitalized Adults with Symptomatic Mild-to-Moderate COVID-19
errVIRUSES-BASEL
IF3.5
err2023-07-06
err7
errOAAI
errMartin, David E.; Pandey, Neelam; Chavda, Purvi; Singh, Gurpreet; Sutariya, Rakesh; Sancilio, Frederic; Tripp, Ralph A.
errShare
errSave
Immunogenicity and protective efficacy of an RSV G S177Q central conserved domain nanoparticle vaccine
errFRONTIERS IN IMMUNOLOGY
IF5.9
err2023-06-29
err1
errOAAI
errBergeron, Harrison C.; Murray, Jackelyn; Juarez, Maria G.; Nangle, Samuel J.; DuBois, Rebecca M.; Tripp, Ralph A.
errShare
errSave
Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein
errVIRUSES-BASEL
IF3.5
err2023-04-27
err5
errOAAI
errBergeron, Harrison C.; Murray, Jackelyn; Arora, Aakash; Castrejon, Ana M. Nunez M.; DuBois, Rebecca M.; Anderson, Larry J.; Kauvar, Lawrence M.; Tripp, Ralph A.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
P
Paul Klenerman
H-index: 137 · Papers: 1.2K
D
Douglas T. Golenbock
H-index: 127 · Papers: 351
R
Ron A. M. Fouchier
H-index: 125 · Papers: 634
L
Lin‐Fa Wang
H-index: 110 · Papers: 716
P
Peter C. Doherty
H-index: 107 · Papers: 696
View more